Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.

about

Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study1

P2860

Q58767039-ECEF4BA4-A808-42DE-83C1-2CEEBC2A49A3

P2860

Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.

Item

http://www.wikidata.org/entity/Q47644799

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Assessment of quality of life ...... f randomized phase III trials.

@en

Assessment of quality of life ...... f randomized phase III trials.

@nl

type

Item

label

Assessment of quality of life ...... f randomized phase III trials.

@en

Assessment of quality of life ...... f randomized phase III trials.

@nl

prefLabel

Assessment of quality of life ...... f randomized phase III trials.

@en

Assessment of quality of life ...... f randomized phase III trials.

@nl

P1476

Assessment of quality of life ...... f randomized phase III trials.

@en

P2093

Krzysztof Adamowicz

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.

Practical approaches to minimize problems with missing quality of life data.

Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer.

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

P2888

s11136-016-1429-9

P304

813-822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11136-016-1429-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27738867

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

phase III clinical trial

Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.

about

P2860

P2860

Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921